Ir al contenido principal
S196 The present and the future of toxins: what's new
sábado 28 enero 2023
14:00 a 15:30
Amphi Bleu - Level 2
SESIÓN ENFOCADA

Moderador(es)

Dr Benjamin ASCHER
Dr Benjamin ASCHER
Cirujano Plástico
Francia
Dr Philippe PICAUT
Dr Philippe PICAUT
PhD - Investigación
Francia

Presentaciones de la sesión

14:00

Introduction by the chairs

14:02

avatar_chairs Dr Philippe PICAUT
Toxins overview: 2023 update

14:10

avatar_chairs Dr Michael CECERLE
LetibotulinumtoxinA: what’s new 1 year after approval? (Croma)

14:10

Part 1 - Future botulinum toxins to arrive on the European market

14:18

avatar_chairs Dr Rui AVELAR
Prabotulinumtoxin longer duration formulation first interim analysis (Evolus)

14:26

avatar_chairs Conor GALLAGHER
DaxibotulinumtoxinA for injection: the new FDA-approved long lasting botulinum toxin formulation (Revance)

14:34

Panel discussion

14:49

Part 2 - Novel botulinum toxins

14:49

avatar_chairs Mickael MACHICOANE
How to boost your usual toxin performance? (Fastox)

14:57

avatar_chairs Xiaoming LIN
RelabotulinumtoxinA: proprietary strain and liquid manufacturing process for a novel long-lasting neuromodulator (Galderma)

15:05

avatar_chairs Jon EDELSON
ET-01 – A phase 2b topical botulinum product candidate (Eirion)

15:13

Panel discussion

15:30

Sesiones recomendadas

¿Tienes una pregunta?

Procesando, por favor espere...

Error

Por favor complete todos los campos requeridos. Estos son los campos que faltan: